Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP555422.RAapU4oT8HWWduIXIN_WT7Ug0izE1e7IGP1yx6KAZdlIE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP555422.RAapU4oT8HWWduIXIN_WT7Ug0izE1e7IGP1yx6KAZdlIE130_assertion type Assertion NP555422.RAapU4oT8HWWduIXIN_WT7Ug0izE1e7IGP1yx6KAZdlIE130_head.
- NP555422.RAapU4oT8HWWduIXIN_WT7Ug0izE1e7IGP1yx6KAZdlIE130_assertion description "[Here, we used low-density arrays, quantitative PCR, and western blotting to determine how HER2 signaling inhibition with lapatinib or PI3K inhibitors affects the expression of genes involved in breast cancer metastatic spread and overall prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP555422.RAapU4oT8HWWduIXIN_WT7Ug0izE1e7IGP1yx6KAZdlIE130_provenance.
- NP555422.RAapU4oT8HWWduIXIN_WT7Ug0izE1e7IGP1yx6KAZdlIE130_assertion evidence source_evidence_literature NP555422.RAapU4oT8HWWduIXIN_WT7Ug0izE1e7IGP1yx6KAZdlIE130_provenance.
- NP555422.RAapU4oT8HWWduIXIN_WT7Ug0izE1e7IGP1yx6KAZdlIE130_assertion SIO_000772 20126311 NP555422.RAapU4oT8HWWduIXIN_WT7Ug0izE1e7IGP1yx6KAZdlIE130_provenance.
- NP555422.RAapU4oT8HWWduIXIN_WT7Ug0izE1e7IGP1yx6KAZdlIE130_assertion wasDerivedFrom befree-20140225 NP555422.RAapU4oT8HWWduIXIN_WT7Ug0izE1e7IGP1yx6KAZdlIE130_provenance.
- NP555422.RAapU4oT8HWWduIXIN_WT7Ug0izE1e7IGP1yx6KAZdlIE130_assertion wasGeneratedBy ECO_0000203 NP555422.RAapU4oT8HWWduIXIN_WT7Ug0izE1e7IGP1yx6KAZdlIE130_provenance.